Difference between revisions of "Neuromuscular blockade"
(Created page with "{{Infobox drug reference | trade_names = | drug_class = | drug_class_color = | uses = | contraindications = | routes = | dosage = }} Neuromuscular blockade involves the use of neuromuscular blocking agents (NMBAs) (i.e. paralytics) to facilitate endotracheal intubation and/or surgical procedures. ==Drugs used== Non-depolarizing agents bind to and INHIBIT acetylcholine receptors at the end plate of the neuromuscular junction. Common examples below include: Ster...") |
|||
| Line 9: | Line 9: | ||
}} | }} | ||
Neuromuscular blockade involves the use of neuromuscular blocking agents (NMBAs) (i.e. paralytics) to facilitate endotracheal intubation and/or surgical procedures. | '''Neuromuscular blockade''' involves the use of neuromuscular blocking agents (NMBAs) (i.e. paralytics) to facilitate endotracheal intubation and/or surgical procedures. | ||
==Drugs used== | ==Drugs used== | ||
Non-depolarizing agents bind to and INHIBIT acetylcholine receptors at the end plate of the neuromuscular junction. Common examples below include: | '''Non-depolarizing agents''' bind to and INHIBIT acetylcholine receptors at the end plate of the neuromuscular junction. Common examples below include: | ||
Steroidal non-depolarizing agents (hepatic and/or renal excreted): | ''Steroidal non-depolarizing agents'' (hepatic and/or renal excreted): | ||
* Rocuronium | * Rocuronium | ||
* Vecuronium | * Vecuronium | ||
''Benzylisoquinolinium non-depolarizing agents'' (broken down by Hoffman Elimination): | |||
Benzylisoquinolinium non-depolarizing agents (broken down by Hoffman Elimination): | |||
* Cisatrocurium (the cis-enantiomer of atrocurium) | * Cisatrocurium (the cis-enantiomer of atrocurium) | ||
'''Depolarizing agents''' on the other hand bind and ACTIVATE acetylcholine receptors causing depolarization of the neuromuscular junction (i.e. muscle contraction) followed by paralysis. The prototypical example being: | |||
Depolarizing agents on the other hand bind and ACTIVATE acetylcholine receptors causing depolarization of the neuromuscular junction (i.e. muscle contraction) followed by paralysis. The prototypical example being: | |||
* Succinylcholine | * Succinylcholine | ||
Depolarizing agents have different implications for neuromuscular blockade monitoring as discussed below. | Depolarizing agents have different implications for neuromuscular blockade monitoring as discussed below. | ||
==Monitoring== | ==Monitoring== | ||
Train of Four | ===Train of Four=== | ||
'''Equipment (Quantitative Monitoring)''' | |||
In order to assess the level of paralysis during an anesthesia event, train of four monitoring (either quantitative or qualitative) is typically used throughout the duration of the procedure (e.g. during routine assessments) and prior to extubation. Quantitative train of four monitoring is the most accurate assessment of neuromuscular blockade and is preferred as it mitigates the risk of residual paralysis and subsequent post-op pulmonary complications<ref>{{Cite web|last=Brull|first=Sorin|title=Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities|url=https://pubs.asahq.org/crawlprevention/governor?content=%2fanesthesiology%2farticle%2f126%2f1%2f173%2f660%2fCurrent-Status-of-Neuromuscular-Reversal-and|url-status=live|access-date=2022-07-03|website=pubs.asahq.org}}</ref>. Equipment that can be used includes: | In order to assess the level of paralysis during an anesthesia event, train of four monitoring (either quantitative or qualitative) is typically used throughout the duration of the procedure (e.g. during routine assessments) and prior to extubation. Quantitative train of four monitoring is the most accurate assessment of neuromuscular blockade and is preferred as it mitigates the risk of residual paralysis and subsequent post-op pulmonary complications<ref>{{Cite web|last=Brull|first=Sorin|title=Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities|url=https://pubs.asahq.org/crawlprevention/governor?content=%2fanesthesiology%2farticle%2f126%2f1%2f173%2f660%2fCurrent-Status-of-Neuromuscular-Reversal-and|url-status=live|access-date=2022-07-03|website=pubs.asahq.org}}</ref>. Equipment that can be used includes: | ||
| Line 41: | Line 39: | ||
* Kinemyography (KMG) | * Kinemyography (KMG) | ||
= | |||
All of the above involve the stimulation of peripheral nerves, the differences being what is actually measured. EMG measures evoked muscle responses (a.k.a. action potentials). AMG measures the acceleration of thumb contraction using Newton's Second Law of Motion (Force = Mass x Acceleration). KMG uses mechanosensors that general measurable electrical signals. All are valid for use in quantitative train of four monitoring. AMG and KMG require unrestricted motion of the hand or muscle interrogated while EMG does not. AMG and KMG are also subject to the phenomenon of "reverse fade." EMG on the other hand can be affected by electrical interference in the operating room (cautery) but nonetheless is usually the monitoring device of choice. | |||
'''Qualitative Monitoring''' | |||
In lieu of EMG, provider may also use a nerve stimulator and palpate for muscle contraction in order to assess depth of paralysis. This is less accurate and generally overestimates recovery from paralysis<ref>{{Cite journal|last=Azizoğlu|first=Mustafa|last2=Özdemir|first2=Levent|date=2021-08-01|title=Quantitative Neuromuscular Monitoring With Train-of-Four Ratio During Elective Surgery: A Prospective, Observational Study|url=https://pubmed.ncbi.nlm.nih.gov/34276037/|journal=Journal of Patient Safety|volume=17|issue=5|pages=352–357|doi=10.1097/PTS.0000000000000874|issn=1549-8425|pmid=34276037}}</ref>. The risk of this is residual paralysis which contributes to higher rates of post-op pulmonary complications. | |||
'''Fade''' | |||
Fade is the progressive decrease in amplitude in response to nerve stimulation as a result of increased levels of paralysis. This is important Of note, fade is generally not observed when depolarizing agents such as succinylcholine are used (instead, there is a uniform decrease in amplitude). Fade may still be observed with depolarizing agents if patients are in phase II of paralysis where there is desensitization of the neuromuscular junction after prolonged acetylcholine channel opening. | |||
===Precautions<!-- List precautions for use of the drug. If none, this section may be removed. -->=== | ===Precautions<!-- List precautions for use of the drug. If none, this section may be removed. -->=== | ||
Revision as of 06:01, 3 July 2022
| Clinical data | |
| Pharmacodynamics | |
| Pharmacokinetics | |
| Physical and chemical data | |
| Article quality | |
| Editor rating | |
|---|---|
| User likes | 0 |
Neuromuscular blockade involves the use of neuromuscular blocking agents (NMBAs) (i.e. paralytics) to facilitate endotracheal intubation and/or surgical procedures.
Drugs used
Non-depolarizing agents bind to and INHIBIT acetylcholine receptors at the end plate of the neuromuscular junction. Common examples below include:
Steroidal non-depolarizing agents (hepatic and/or renal excreted):
- Rocuronium
- Vecuronium
Benzylisoquinolinium non-depolarizing agents (broken down by Hoffman Elimination):
- Cisatrocurium (the cis-enantiomer of atrocurium)
Depolarizing agents on the other hand bind and ACTIVATE acetylcholine receptors causing depolarization of the neuromuscular junction (i.e. muscle contraction) followed by paralysis. The prototypical example being:
- Succinylcholine
Depolarizing agents have different implications for neuromuscular blockade monitoring as discussed below.
Monitoring
Train of Four
Equipment (Quantitative Monitoring)
In order to assess the level of paralysis during an anesthesia event, train of four monitoring (either quantitative or qualitative) is typically used throughout the duration of the procedure (e.g. during routine assessments) and prior to extubation. Quantitative train of four monitoring is the most accurate assessment of neuromuscular blockade and is preferred as it mitigates the risk of residual paralysis and subsequent post-op pulmonary complications[1]. Equipment that can be used includes:
- Electromyography (EMG)
- Acceleromyography (AMG)
- Kinemyography (KMG)
All of the above involve the stimulation of peripheral nerves, the differences being what is actually measured. EMG measures evoked muscle responses (a.k.a. action potentials). AMG measures the acceleration of thumb contraction using Newton's Second Law of Motion (Force = Mass x Acceleration). KMG uses mechanosensors that general measurable electrical signals. All are valid for use in quantitative train of four monitoring. AMG and KMG require unrestricted motion of the hand or muscle interrogated while EMG does not. AMG and KMG are also subject to the phenomenon of "reverse fade." EMG on the other hand can be affected by electrical interference in the operating room (cautery) but nonetheless is usually the monitoring device of choice.
Qualitative Monitoring
In lieu of EMG, provider may also use a nerve stimulator and palpate for muscle contraction in order to assess depth of paralysis. This is less accurate and generally overestimates recovery from paralysis[2]. The risk of this is residual paralysis which contributes to higher rates of post-op pulmonary complications.
Fade
Fade is the progressive decrease in amplitude in response to nerve stimulation as a result of increased levels of paralysis. This is important Of note, fade is generally not observed when depolarizing agents such as succinylcholine are used (instead, there is a uniform decrease in amplitude). Fade may still be observed with depolarizing agents if patients are in phase II of paralysis where there is desensitization of the neuromuscular junction after prolonged acetylcholine channel opening.
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
- ↑ Brull, Sorin. "Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities". pubs.asahq.org. Retrieved 2022-07-03.
- ↑ Azizoğlu, Mustafa; Özdemir, Levent (2021-08-01). "Quantitative Neuromuscular Monitoring With Train-of-Four Ratio During Elective Surgery: A Prospective, Observational Study". Journal of Patient Safety. 17 (5): 352–357. doi:10.1097/PTS.0000000000000874. ISSN 1549-8425. PMID 34276037.